Literature DB >> 35691467

Spinal CCK1 Receptors Contribute to Somatic Pain Hypersensitivity Induced by Malocclusion via a Reciprocal Neuron-Glial Signaling Cascade.

Ting Xiang1, Jia-Heng Li2, Han-Yu Su2, Kun-Hong Bai2, Shuang Wang3, Richard J Traub4, Dong-Yuan Cao5.   

Abstract

Recent studies have shown that the incidence of chronic primary pain including temporomandibular disorders (TMD) and fibromyalgia syndrome (FMS) often exhibit comorbidities. We recently reported that central sensitization and descending facilitation system contributed to the development of somatic pain hypersensitivity induced by orofacial inflammation combined with stress. The purpose of this study was to explore whether TMD caused by unilateral anterior crossbite (UAC) can induce somatic pain hypersensitivity, and whether the cholecystokinin (CCK) receptor-mediated descending facilitation system promotes hypersensitivity through neuron-glia cell signaling cascade. UAC evoked thermal and mechanical pain hypersensitivity of the hind paws from day 5 to 70 that peaked at week 4 post UAC. The expression levels of CCK1 receptors, interleukin-18 (IL-18) and IL-18 receptors (IL-18R) were significantly up-regulated in the L4 to L5 spinal dorsal horn at 4 weeks post UAC. Intrathecal injection of CCK1 and IL-18 receptor antagonists blocked somatic pain hypersensitivity. IL-18 mainly co-localized with microglia, while IL-18R mainly co-localized with astrocytes and to a lesser extent with neurons. These findings indicate that the signaling transduction between neurons and glia at the spinal cord level contributes to the descending pain facilitation through CCK1 receptors during the development of the comorbidity of TMD and FMS. PERSPECTIVE: CCK1 receptor-dependent descending facilitation may mediate central mechanisms underlying the development of widespread somatic pain via a reciprocal neuron-glial signaling cascade, providing novel therapeutic targets for the clinical treatment of TMD and FMS comorbidities.
Copyright © 2022 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholecystokinin; IL-18; comorbidity; fibromyalgia syndrome; temporomandibular disorders

Mesh:

Substances:

Year:  2022        PMID: 35691467      PMCID: PMC9560966          DOI: 10.1016/j.jpain.2022.05.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.383


  86 in total

Review 1.  Immune responses of microglia in the spinal cord: contribution to pain states.

Authors:  Dominic Schomberg; Julie K Olson
Journal:  Exp Neurol       Date:  2011-12-27       Impact factor: 5.330

Review 2.  Fibromyalgia syndrome and temporomandibular disorders with muscular pain. A review.

Authors:  Ana Maria Moreno-Fernández; Emilio Jiménez-Castellanos; Alejandro Iglesias-Linares; Débora Bueso-Madrid; Ana Fernández-Rodríguez; Manuel de Miguel
Journal:  Mod Rheumatol       Date:  2017-02-01       Impact factor: 3.023

3.  Interactions between the immune and nervous systems in pain.

Authors:  Ke Ren; Ronald Dubner
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

Review 4.  Pro-nociceptive action of cholecystokinin in the periaqueductal grey: a role in neuropathic and anxiety-induced hyperalgesic states.

Authors:  T A Lovick
Journal:  Neurosci Biobehav Rev       Date:  2008-01-18       Impact factor: 8.989

Review 5.  Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11).

Authors:  Rolf-Detlef Treede; Winfried Rief; Antonia Barke; Qasim Aziz; Michael I Bennett; Rafael Benoliel; Milton Cohen; Stefan Evers; Nanna B Finnerup; Michael B First; Maria Adele Giamberardino; Stein Kaasa; Beatrice Korwisi; Eva Kosek; Patricia Lavand'homme; Michael Nicholas; Serge Perrot; Joachim Scholz; Stephan Schug; Blair H Smith; Peter Svensson; Johan W S Vlaeyen; Shuu-Jiun Wang
Journal:  Pain       Date:  2019-01       Impact factor: 6.961

6.  Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.

Authors:  Caitlin E O'Brien; Liana Bonanno; Hui Zhang; Tony Wyss-Coray
Journal:  Mol Neurodegener       Date:  2015-12-21       Impact factor: 14.195

7.  IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties.

Authors:  Onusa Thamsermsang; Pravit Akarasereenont; Tawee Laohapand; Uraiwan Panich
Journal:  BMC Complement Altern Med       Date:  2017-01-10       Impact factor: 3.659

8.  CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model.

Authors:  Zhi-Yuan Liu; Zhi-Wen Song; Shi-Wu Guo; Jun-Sheng He; Shen-Yu Wang; Jian-Guo Zhu; Hui-Lin Yang; Jin-Bo Liu
Journal:  CNS Neurosci Ther       Date:  2019-04-07       Impact factor: 5.243

9.  Malocclusion Generates Anxiety-Like Behavior Through a Putative Lateral Habenula-Mesencephalic Trigeminal Nucleus Pathway.

Authors:  Xin Liu; Kai-Xiang Zhou; Nan-Nan Yin; Chun-Kui Zhang; Ming-Hong Shi; Hong-Yun Zhang; Dong-Mei Wang; Zi-Jun Xu; Jing-Dong Zhang; Jin-Lian Li; Mei-Qing Wang
Journal:  Front Mol Neurosci       Date:  2019-07-30       Impact factor: 5.639

10.  Over-expression of CCK1 Receptor Reverse Morphine Dependence.

Authors:  Lijing Hao; Di Wen; Hongyan Gou; Feng Yu; Bin Cong; Chunling Ma
Journal:  Int J Pept Res Ther       Date:  2018-04-02       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.